Methyl 1-C-{(1S,4aS,6R,7S,7aS)-6,7-dihydroxy-7-methyl-1-[(3-methylbutanoyl)oxy]-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-yl}-beta-D-glucopyranoside, with CAS number 88586-75-8, is a complex glycoside characterized by its unique structural features. This compound contains a cyclopentapyran core, which is a fused bicyclic structure, and is substituted with multiple hydroxyl groups, contributing to its potential solubility in polar solvents. The presence of a beta-D-glucopyranoside moiety indicates that it is a glycoside, which may influence its biological activity and interactions with other molecules. The methyl and 3-methylbutanoyl substituents suggest that it may have lipophilic characteristics, potentially affecting its permeability and bioavailability. This compound may exhibit various pharmacological properties, making it of interest in medicinal chemistry and natural product research. Its stereochemistry, indicated by the specific configuration at several chiral centers, is crucial for its biological activity and interaction with biological targets. Overall, this substance represents a complex interplay of structural features that may confer unique chemical and biological properties.

methyl 1-C-{(1S,4aS,6R,7S,7aS)-6,7-dihydroxy-7-methyl-1-[(3-methylbutanoyl)oxy]-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-yl}-beta-D-glucopyranoside

88586-75-8: Methyl 1-C-{(1S,4aS,6R,7S,7aS)-6,7-dihydroxy-7-methyl-1-[(3-methylbutanoyl)oxy]-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-yl}-beta-D-glucopyranoside, with CAS number 88586-75-8, is a complex glycoside characterized by its unique structural features. This compound contains a cyclopentapyran core, which is a fused bicyclic structure, and is substituted with multiple hydroxyl groups, contributing to its potential solubility in polar solvents. The presence of a beta-D-glucopyranoside moiety indicates that it is a glycoside, which may influence its biological activity and interactions with other molecules. The methyl and 3-methylbutanoyl substituents suggest that it may have lipophilic characteristics, potentially affecting its permeability and bioavailability. This compound may exhibit various pharmacological properties, making it of interest in medicinal chemistry and natural product research. Its stereochemistry, indicated by the specific configuration at several chiral centers, is crucial for its biological activity and interaction with biological targets. Overall, this substance represents a complex interplay of structural features that may confer unique chemical and biological properties.

CAS 88586-75-8

methyl 1-C-{(1S,4aS,6R,7S,7aS)-6,7-dihydroxy-7-methyl-1-[(3-methylbutanoyl)oxy]-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-yl}-beta-D-glucopyranoside

purine, 6-(heptylthio)-

Ref: IN-DA004DHT